Table 1.
Baseline participant characteristics
| Baseline Characteristics | Fish Oil (n = 70) | Placebo (n = 71) | P-value |
|---|---|---|---|
| Age, years, median (IQR) | 57 (54, 64) | 59 (55, 66) | 0.37 |
| Sex, female, n (%) | 34 (48.6) | 34 (47.9) | 0.94 |
| Regular aspirin or NSAID use, n (%) | 47 (67.1) | 37 (52.1) | 0.07 |
| Genotype, n (%) | |||
| G/G | 26 (37.1) | 25 (35.2) | 0.97 |
| G/T | 25 (35.7) | 26 (36.6) | |
| T/T | 19 (27.1) | 20 (28.2) | |
| Red blood cell phospholipid fatty acids, as % of total | |||
| Linolenic Acid, median (IQR) | 11.2 (9.99, 12.6) | 11.2 (9.95, 12.6) | 0.89 |
| Arachidonic acid, median (IQR) | 16.7 (14.7, 18.1) | 17.2 (15.2, 18.5) | 0.19 |
| Eicosapentaenoic acid, median (IQR) | 0 (0, 0.57) | 0.35 (0, 0.64) | 0.29 |
| Docosahexaenoic acid, median (IQR) | 3.48 (2.89, 4.51) | 3.55 (2.82, 4.47) | 0.93 |
P values for baseline differences determined using Wilcoxon Rank Order Sum for continuous variables and λ2 for proportions